Sharp Ace (603168.SH): Compound topicamide eye drops obtained drug registration certificate

Zhitongcaijing · 2d ago

Zhitong Finance App News, ShapeAce (603168.SH) issued an announcement. Recently, the company received a “Drug Registration Certificate” for compound topicamide eye drops issued by the State Drug Administration. This drug is suitable for dilating pupils and regulating paralysis for the purpose of diagnosis and treatment. The company obtained its “Drug Registration Certificate” this time, which will further enrich the company's product categories and help optimize the company's product layout.